Amniotic Membrane Market Overview
As per the analysis by Market Research Future (MRFR), the global amniotic membrane market is slated to reach USD 1210.9 million by 2023, at a moderate 12.16% CAGR over the review period (2018-2023).
Influential factors estimated to impact the global market for amniotic membranes during the evaluation period positively are the increasing research and development activities to discover benefits of amniotic membranes, rise in geriatric population globally, and the growing cases of amniotic membrane-based transplants globally.
Get Free Sample Report at https://www.marketresearchfuture.com/sample_request/5645
MRFR identifies Alliqua BioMedical, Inc. (U.S.), Amnio Technology, LLC (U.S.), Amniox Medical, Inc. (U.S.), Applied Biologics (U.S.), Human Regenerative Technologies, LLC (U.S.), Integra LifeSciences (U.S.), Katena Products, Inc. (U.S.), MiMedx (U.S.), and Osiris Therapeutics, Inc. (U.S.), Skye Biologics Inc. (California),
The leading players operating in the global amniotic membrane market are expected to focus on innovative product launches, geographical expansions by entering untapped markets in developing countries. Additionally, business acquisitions and the increasing adoption of e-commerce for product distribution are expected to drive the market over the forecast period.
The global market for amniotic membrane has been segmented based on the type, application, and end-users.
The types of amniotic membranes available in the market are cryopreserved amniotic membrane and lyophilized amniotic membrane. The cryopreserved amniotic membrane segment is poised to register the largest market share of USD 1,090.08 million at a CAGR of 10.44% by 2024. This is attributed to the rising number of ocular surgeries, growing cases of reconstruction and cosmetic surgeries, and the increasing prevalence of pressure leg and venous ulcers. On the other hand, the lyophilized amniotic membrane segment is slated to register the highest CAGR of 14.18% over the evaluation period. Amniotic membranes have applications in several healthcare fields such as ophthalmology, prenatal diagnosis, regenerative medicine, stem cell biology, surgical wounds, and others. Additionally, based on end-users, the amniotic membrane market is segmented into ambulatory surgical centers, hospitals and clinics, research centers and laboratories, and others.
July 2019 – Researchers from the Royan Research Institute in Iran developed biological wound dressings from amniotic membranes.
July 2019 – Madison Hospital, US, introduced a new birth tissue donor program where new mothers could donate their amniotic membrane, amniotic fluid, chronic membrane, the placenta as well as their umbilical cord tissue and veins.
Based on the region, the global amniotic market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas are the largest region in the market and are slated to account for the largest market share over the assessment period at a CAGR of 13.28%. North America is the major contributor to the amniotic market in the region owing to the well-established healthcare industry, and favorable government policies towards the expansion of the medical sector.
Europe is a significant market for amniotic membranes and is poised to reach a valuation of USD 681.71 million by 2023. The European amniotic membranes market is driven by influential factors such as the increasing prevalence of cicatricial pemphigoid and the Stevens-Johnsons syndrome. Additionally, the growing cases of chemical and thermal burns in Europe have increased the demand for conjunctival surface reconstruction, and ocular surface reconstruction. Germany, followed by France, is expected to contribute substantially to the revenue generation of the European amniotic membrane market over the evaluation period.
Browse Complete 116 Pages Premium Research Report Enabled with 100+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645
Asia Pacific (APAC) region has been assessed as the fastest-growing region of the global amniotic membrane market at a 13.60% CAGR over the review period. The growing awareness for the benefits of amniotic membranes, along with the rising research and development activities, and government support towards the improvement of the healthcare sector is expected to drive the asia pacific market over the review period.
The Middle East and Africa (MEA) Region are expected to witness gradual growth over the assessment period, owing to the weak healthcare sectors with lack of technological advancements in some regions of Africa. The middle eastern developing countries such as Kuwait, Saudi Arabia, and the United Arab Emirates are expected to contribute to the majority of the market share acquired in this region over the assessment period.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar